Skip to main content
Back
Watch Compare

TELA Bio, Inc.

Data quality: 100%
TELA
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.57
▼ $0.03 (-4.73%)
Mkt Cap: 26.52 M
Price
$0.59
Mkt Cap
26.52 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 28.48% annually over 5 years — strong growth
Debt/Equity of 26.65 — high leverage
Negative free cash flow of -28.67 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 12.64%
Capital efficient — spends only 0.56% of revenue on capex

Growth

Revenue Growth (5Y)
28.48%
Above sector avg (1.82%)
Revenue (1Y)15.84%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-723.04%
Below sector avg (-53.34%)
ROIC-57.29%
Net Margin-48.37%
Op. Margin-42.05%

Safety

Debt / Equity
26.65
Above sector avg (0.31)
Current Ratio3.30
Interest Coverage-6.44

Valuation

PE (TTM)
-0.68
Above sector avg (-1.47)
P/B Ratio17.03
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.7 -1.5
P/B 17.0 1.6
ROE % -723.0 -53.3
Net Margin % -48.4 -41.5
Rev Growth 5Y % 28.5 1.8
D/E 26.7 0.3

Analyst Price Target

5 analysts
Buy
Current
$0.57
+296.5%
Target
$2.25
$1.00
$2.00
$3.25
Forecast
Forward P/E -1.01
Forward EPS -$0.56
Est. Revenue 97.24 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.56
-$0.76 – -$0.43
 97.24 M 5
FY2026 -$0.67
-$0.88 – -$0.57
 86.75 M 5

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.18 -$0.17 +6.6%
Q32025 -$0.20 -$0.19 +5.0%
Q22025 -$0.19 -$0.22 -18.9%
Q12025 -$0.21 -$0.25 -20.5%

ETFs Holding This Stock

JSCGX JSCGX
2.60% weight
JSIGX JSIGX
2.60% weight
JMCGX JMCGX
0.78% weight
JMIGX JMIGX
0.78% weight
BRSIX BRSIX
0.06% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 15.84% Revenue Growth (3Y) 17.19%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 28.48% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 80.28 M Net Income (TTM) -38.83 M
ROE -723.04% ROA -60.15%
Gross Margin 67.69% Operating Margin -42.05%
Net Margin -48.37% Free Cash Flow (TTM) -28.67 M
ROIC -57.29% FCF Growth (3Y) N/A
Safety
Debt / Equity 26.65 Current Ratio 3.30
Interest Coverage -6.44 Asset Turnover 1.24
Working Capital 39.07 M Tangible Book Value 103,000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.68 Forward P/E N/A
P/B Ratio 17.03 P/S Ratio 0.33
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -108.11%
Market Cap 26.52 M Enterprise Value 38.30 M
Per Share
EPS (Diluted TTM) -0.83 Revenue / Share 1.79
FCF / Share -0.64 OCF / Share -0.63
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.56% FCF Conversion 73.83%
SBC-Adj. FCF -32.73 M Growth Momentum -12.64

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 80.28 M 69.30 M 58.45 M 41.42 M 29.46 M
Net Income -38.83 M -37.84 M -46.66 M -44.30 M -33.28 M
EPS (Diluted) -0.83 -1.33 -2.04 -2.72 -2.30
Gross Profit 54.34 M 46.49 M 40.11 M 27.04 M 18.81 M
Operating Income -33.76 M -34.12 M -44.08 M -39.01 M -29.45 M
EBITDA — — — — —
R&D Expenses 9.22 M 8.81 M 9.62 M 8.94 M 6.74 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 5.25 M 5.29 M 5.22 M 4.05 M 3.60 M
Income Tax 230,000.0 -144,000.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 81.42 M 86.57 M 78.05 M 67.86 M 62.54 M
Total Liabilities 75.11 M 58.11 M 59.17 M 53.55 M 42.45 M
Shareholders' Equity 6.31 M 28.46 M 18.88 M 14.31 M 20.10 M
Total Debt 55.65 M 41.12 M 40.52 M 39.92 M 31.49 M
Cash & Equivalents 50.85 M 52.67 M 46.73 M 42.02 M 43.93 M
Current Assets 75.58 M 78.07 M 71.73 M 62.45 M 59.06 M
Current Liabilities 17.98 M 15.60 M 16.97 M 12.40 M 10.58 M